Introduction cules for recruitment to Fas via death domain interactions. Tumor necrosis factor (TNF) is a proinflammatory cyto-
The second family of signal transducing proteins utikine whose pleiotropic biological properties are signaled lized by the TNFR superfamily are the TNFR-associated through two distinct cell surface receptors (reviewed by factors (TRAFs). TRAF1 and TRAF2 were biochemically Tartaglia and Goeddel, 1992; Rothe et al., 1992) . TNF purified as TNFR2-associated proteins of 45 and 56 kDa, receptor 1 (TNFR1; 55-60 kDa) and TNFR2 (75) (76) (77) (78) (79) (80) respectively (Rothe et al., 1994) . TRAF1 and TRAF2 exist are expressed on most cell types and are ‫%03ف‬ identiin a multimeric complex that interacts via TRAF2 with cal in their extracellular, cysteine-rich, ligand-binding the signaling domains of both TNFR2 and CD40 (Rothe regions Schall et al., 1990; Smith et al., 1994 Smith et al., , 1995 . TRAF3 was identified by two-hybrid et al., 1990) . This extracellular domain architecture is interaction cloning as a CD40-associated protein of 64 characteristic of the larger TNFR superfamily, whose kDa (Hu et al., 1994; Cheng et al., 1995; Mosialos et al., members include the Fas antigen, CD27, CD30, CD40, 1995; Sato et al., 1995) . The three known TRAFs share and several other receptors (reviewed by Smith et al., a highly conserved C-terminal "TRAF domain" of about 1994). With the exception of TNFR1 and Fas, both of 150 amino acids, which is involved in oligomerization which can induce programmed cell death through a and receptor association (Rothe et al., 1994 ; shared ‫08ف‬ amino acid "death domain" of 28% identity Cheng et al., 1995; Sato et al., 1995) . Overexpression of (Tartaglia et al., 1993a; Itoh and Nagata, 1993) , the cyto-TRAF2, but not TRAF1 or TRAF3, activates NF-B (Rothe plasmic domains of receptors in this superfamily share et al., 1995) . Furthermore, a truncated TRAF2 lacking no obvious sequence similarities.
its N-terminal RING finger acts as a dominant-negative Until recently, the molecular mechanisms utilized by inhibitor of NF-B activation mediated by both TNFR2 members of the TNFR family to generate cellular reand CD40 . Therefore, TRAF2 is a sponses have remained largely undefined. However, common mediator of signal transduction by TNFR2 and during the past year an improved understanding of these CD40 and, perhaps, by other members of the TNFR mechanisms has begun to emerge with the identification superfamily. of two distinct classes of receptor-associated proteins, Two of the most important activities of TNF, apoptosis both of which appear to couple these receptors to downand NF-B activation, are signaled by TNFR1 following stream signaling cascades.
its oligomerization by the trimeric TNF (Tartaglia and Three intracellular proteins that contain death doGoeddel, 1992) . We recently reported the molecular mains were identified through yeast two-hybrid interaccloning and characterization of TRADD, a novel protein tion cloning by virtue of their interactions with the death that specifically interacts with the death domain of domains of TNFR1 and Fas. TRADD is a 34 kDa protein TNFR1 and activates signaling pathways for both of these activities when overexpressed (Hsu et al., 1995) . that interacts specifically with TNFR1 (Hsu et al., 1995), The amino acid sequences of murine and human FADD are aligned. or with mouse immunoglobulin G (IgG) control antibody (lanes 1 and Identical residues are stippled The death domain of FADD extends 2). Coprecipitating TRADD was detected by immunoblot analysis from amino acids 104-177, as indicated by the brackets. using rabbit anti-TRADD antiserum. Positions of molecular mass standards (in kilodaltons) are shown.
for NF-B activation by these two receptors (Rothe et al., 1994 . The interaction of TRADD with TRAF2 was verified in yeast two-hybrid interaction assays using Here we show that under normal conditions the associafull-length TRAF2. TRADD was also found to interact tion of TRADD with TNFR1 is TNF dependent. We also strongly with TRAF1, and more weakly with TRAF3, in show that TRADD directly interacts with TRAF2 through two-hybrid assays (data not shown). its N-terminal half and with FADD through its C-terminal
The two-hybrid screen also yielded cDNA clones endeath domain. Furthermore, dominant-negative mucoding full-length murine FADD and the C-terminal 126 tants of TRAF2 and FADD can block TNF-mediated NFamino acids of murine FADD. The 205 amino acid murine B activation and cell death, respectively. Taken to-FADD shares 73% identity with human FADD throughout gether, these data suggest that TNFR1 utilizes distinct the region (amino acids 1-177) comprising the effector TRADD-dependent mechanisms to activate signaling and death domains, whereas the C-terminal ‫03ف‬ amino pathways for NF-B activation and apoptosis.
acids are very poorly conserved (Figure 2 ). Since FADD was originally identified owing to its interaction with Results Fas (Boldin et al., 1995a; Chinnaiyan et al., 1995) , we compared the relative strength of the TRADD-FADD and
Interaction of TRADD with TNFR1
Fas-FADD interactions in two-hybrid assays. These exIs TNF Dependent periments indicated that FADD consistently interacts We previously demonstrated that TRADD specifically 10-to 20-fold more strongly with TRADD than with Fas associates with TNFR1 when both proteins are overex-(data not shown). pressed (Hsu et al., 1995) . To determine whether the Since TRAF1, TRAF2, and FADD interact strongly with TRADD-TNFR1 interaction is physiologically relevant, TRADD in two-hybrid tests, we performed coimmunowe performed the following experiment using human precipitation assays to test whether these proteins U937 cells. Lysates from cells that had been treated might interact in human cells. An expression vector enwith TNF for 15 min or left untreated were immunoprecoding TRADD was transfected alone or with expression cipitated with a nonagonistic monoclonal antibody vectors encoding Flag epitope-tagged TRAF1, TRAF2, directed against the extracellular domain of TNFR1.
or FADD into human embryonic kidney 293 cells. Cell Coprecipitating TRADD was detected by immuoblot extracts were immunoprecipitated using a monoclonal analysis using a TRADD-specific polyclonal antiserum.
antibody against the Flag epitope, and coprecipitating TRADD coprecipitated with TNFR1 only in the TNF-TRADD was detected by Western blotting with antitreated cell lysates (Figure 1 ). Since TNF induces tri-TRADD polyclonal antibody. TRAF1, TRAF2, and FADD merization of TNFR1, this result suggests that the rewere individually able to coprecipitate TRADD (Figure 3 ). cruitment of TRADD to TNFR1 probably depends on a properly aggregated TNFR1 cytoplasmic domain.
Mapping of TRADD-TRAF2 and TRADD-FADD Identification of TRAF2 and FADD Interaction Domains as TRADD-Interacting Proteins
To determine the region(s) of TRADD responsible for To identify potential downstream components of the interaction with TRAF2 and FADD, a series of N-terminal TNFR1/TRADD signaling pathway, we used the yeast and C-terminal TRADD truncation mutants were examtwo-hybrid system (Fields and Song, 1989) to screen ined in two-hybrid assays ( Figure 4A ). A C-terminal delecDNA libraries for TRADD-interacting proteins. Multiple tion mutant of TRADD lacking its entire death domain cDNA clones were obtained that encode several distinct retained TRAF2-binding activity. This demonstrated that proteins. As expected, two classes of clones encoded the TRAF2-binding domain resides in the N-terminal half TRADD itself or portions of the intracellular region of (amino acids 1-169) of TRADD. A further C-terminal TNFR1. Surprisingly, many of the cDNA clones were deletion mutant (TRADD ) failed to interact with found to encode portions of TRAF2, a protein that inter-TRAF2. In contrast, TRADD interacts with FADD through its C-terminal death domain (amino acids 195-312). This acts with TNFR2 and CD40 and transduces the signal is the same region of TRADD that is required for interaction with the death domain of TNFR1 (Hsu et al., 1995) .
Deletion studies on TRAF2 indicate that its TRAF-C domain (amino acids 348-501) was sufficient for TRADD binding ( Figure 4B ). Previous studies had shown that the entire TRAF domain (amino acids 264-501) of TRAF2 can self-associate and interact with TRAF1, TNFR2, and CD40 (Rothe et al., 1994 .
TRADD Recruits TRAF Proteins to TNFR1
The interaction of TRADD with TNFR1 and TRAFs occurs immunoprecipitated with agonistic polyclonal antibodies against the extracellular domain of TNFR1, and coprecipitating TRAF proteins were detected by Western blotting with an anti-Flag monoclonal antibody. In lysates prepared from cells programmed for ectopic expression of TNFR1 and TRAF1 or TRAF2, antibody against TNFR1 failed to coprecipitate TRAF proteins ( Figure 5A ). This result, which suggests that no direct interaction occurs between the TNFR1 and TRAF1 or TRAF2, is in agreement with results obtained previously by yeast two-hybrid interaction assays . However, when the same experiments were performed on lysates from cells that also expressed TRADD, both TRAF1 and TRAF2 were coimmunoprecipitated with TNFR1 ( Figure 5A ). These results provide evidence that TRADD can serve as an adaptor protein and recruit TRAF1, TRAF2, or both to TNFR1.
Since TRAF2 is capable of interacting with both TNFR2 and TRADD, we also considered the possibility that TRAF2 could recruit TRADD to the TNFR2 receptor complex. This was examined by cotransfection and immunoprecipitation experiments similar to those described above for TNFR1. However, no ternary TNFR2-TRADD-TRAF2 complex could be detected (data not shown), demonstrating that TRAF2 cannot simultaneously bind to both TNFR2 and TRADD. This finding suggests that TNFR2 and TRADD, both of which interact with the C-terminal TRAF domain of TRAF2 (see Figure  4B ; Rothe et al., 1994) , compete for the same, or an parts, a coiled-coil (CC) region and a C-terminal (TRAF-C) region FADD coprecipitated with Fas, consistent with previous (Rothe et al., 1994) . Transformation mixes were plated on synthetic results (Chinnaiyan et al., 1995) , whereas no detectable dextrose plates lacking tryptophan and leucine. Filter assays were FADD coprecipitated with TNFR1 ( Figure 5B ). In conperformed for ␤-galactosidase activity. Plus signs represent blue color development; minus signs indicate no color development.
trast, when TNFR1 and FADD were expressed in the in the TNFR1 complex suggests that it may also be involved in signaling TNFR1 responses. However, our previous experiments using a dominant-negative mutation of TRAF2 lacking the N-terminal 86 amino acids that comprise the RING finger domain (TRAF2 ) failed to demonstrate a role for TRAF2 in TNFR1-initiated NF-B activation . To examine further a potential role for TRAF2 in NF-B activation by TNFR1, we selected the 293 cell line, since electrophoretic mobility shift assays have shown that TNF activates NF-B exclusively through endogenous TNFR1 in these cells .
We reasoned that our earlier failure to see an effect of TRAF2(87-501) on signaling through endogenous TNFR1 might be related to the stability of the TNFR1-TRADD-TRAF complex. In those experiments, TNF stimulation had been performed shortly after transfection, perhaps before the newly synthesized TRAF2(87-501) could displace endogenous TRAF1/TRAF2 from the complex. Therefore, we performed a time course experiment in which TNF was added at various times following TRAF2(87-501) transfection ( Figure 6 ). We found that 293 cells transfected with a control expression vector responded to TNF with an approximately 20-fold increase in NF-B reporter gene activity. When TNF stimulation was performed 16 hr after transfection with the TRAF2(87-501) expression vector, NF-B activation was only partially compromised (approximately 7-fold acti- completely blocked activation. In contrast, overexpression of TRAF2(87-501) had no effect on IL-1-mediated NF-B activation (Figure 7) . These results provide strong presence of TRADD, FADD could be detected in the antievidence that the TRAF2(87-501) dominant-negative TNFR1 immune complex. However, even under these mutant is inhibiting NF-B activation in a specific manconditions, the amount of FADD that coprecipitated with ner and that TRAF2 plays an important role in TNFR1 TNFR1 was less than with Fas. The addition of TRAF1 signaling. and TRAF2 did not inhibit, but rather slightly enhanced, the ability of TRADD to recruit FADD to TNFR1 ( Figure  5B ). This result shows that TRADD can simultaneously The Apoptotic Pathway Activated by TNFR1 Does Not Require TRAF2 recruit TRAF proteins and FADD to TNFR1. Furthermore, these experiments suggest that, whereas TRADD-FADD Two important activities of TNF signaled through TNFR1 are activation of NF-B and induction of apoptosis. Ovand TRADD-TNFR1 complexes are relatively stable, trimeric TNFR1-TRADD-FADD complexes may exist only erexpression of the TNFR1-associated protein TRADD can trigger both activities by activating two distinct sigtransiently or may require other proteins for their stabilization.
naling pathways (Hsu et al., 1995) . However, overexpression of TRAF2 activates NF-B , but does not induce cell death (H. H. and D. V. G., unpub-NF-B Activation by TNFR1 Requires TRAF2
lished data), suggesting that TRAF2 may not be an essential component of the TNFR1-TRADD apoptotic sigThe activation of NF-B by TNFR2 and CD40 is mediated by TRAF2 (Rothe et al., 1995) . The presence of TRAF2 naling cascade. To examine further whether TRAF2 completely blocked cell death (Table 1) . Taken together, these observations strongly support a model for signaling by the TNFR1 complex in which TRAF2 is dispensable for apoptosis, but essential for NF-B activation.
The Death Domain of FADD Inhibits TNF-Induced Apoptosis Overexpression of FADD has been shown to induce programmed cell death (Boldin et al., 1995a; Chinnaiyan et al., 1995) . This activity requires only amino acids 1-117 of FADD (Chinnaiyan et al., 1995 et al., 1995) . Importantly, FADD(80-205) was a potent inhibitor of TNF-mediated apoptosis, blocking cell death as effectively as CrmA (Table 1) . Similar results were obtained using mouse NIH 3T3 cells (data not shown). It has been shown previously that overexpression of either TRADD (Hsu et al., 1995) or TNFR1 (Boldin et al., 1995b) triggers cell death, presumably through an aggregation phenomenon that activates a TNFR1 signaling cascade. However, when 293 cells (Figure 7 these FADD(80-205)-induced levels. FADD(80-205) also failed to inhibit NF-B activation triggered by overexpression of TRADD or TNFR1 (data not shown). These contributes to apoptosis, we studied the effect of the results suggest that FADD does not play a role in the TRAF2 dominant-negative mutant on TNF-mediated kill-TNFR1-TRADD signaling cascade leading to NF-B acing of HeLa cells, a process which is signaled by TNFR1 tivation. (Tartaglia et al., 1993b) . In this assay (Hsu et al., 1995) , cells are cotransfected with a ␤-galactosidase expression plasmid. The cells are treated 36 hr later with TNF Discussion for 12 hr and then scored for cell death. Overexpression of TRAF2(87-501) had no protective effect in these Recently, several novel proteins have been identified that interact with members of the TNFR superfamily to assays, whereas CrmA, a known inhibitor of TNF-mediated apoptosis Enari et al., 1995) initiate intracellular signal transduction events (Rothe et We transiently transfected 293 cells (2 ϫ 10 5 ) with the indicated expression vectors (1 g) and analyzed them 24 hr later by phase-contrast microscopy. Scale bar is 50 m. Hu et al., 1994; Boldin et al., 1995a; Cheng et TNFR1 death domains would then provide a high affinity binding site for TRADD, perhaps itself in a preassociated Chinnaiyan et al., 1995; Hsu et al., 1995; Mosialos et al., 1995; Sato et al., 1995; Stanger et al., 1995) . state ( Figure 9) . A yeast two-hybrid screen was performed to identify These signaling proteins fall into two structural classes, containing either death domains (TRADD, FADD, and TRADD-interacting proteins as candidate signal transducers for the NF-B and apoptotic pathways. We iso-RIP) or TRAF domains (TRAF1, TRAF2, and TRAF3). The death domain-containing proteins are involved in signallated several clones encoding TRAF2, a 56 kDa protein originally purified through its association with TNFR2 ing by TNFR1 and Fas antigen, two receptors which themselves contain death domains. Therefore, death (Rothe et al., 1994) and later shown to be a common mediator of NF-B activation by TNFR2 and CD40 domains, in addition to their clear involvement in apoptotic signaling, appear to define sequences involved in . Thus, the two known classes of signal transducers for the TNFR family, TRAF domain protein-protein interactions. In contrast, the TRAF domain proteins interact with receptors (TNFR2 and CD40) and death domain proteins, are capable of direct interaction. We also isolated cDNAs encoding FADD, a death that have no recognizable domains or motifs. The results of these initial cloning experiments seemed to confirm domain-containing protein previously shown to interact with Fas and to trigger cell death when overexpressed earlier predictions (Dembic et al., 1990; Lewis et al., 1991; Goodwin et al., 1991 ) that TNFR1 and TNFR2 (Boldin et al., 1995a; Chinnaiyan et al., 1995) . would be found to activate independent and distinct signal transduction pathways.
TRADD-TRAF2 Interaction and Activation of NF-B TRADD interacts with the death domain of TNFR1 to initiate distinct signaling cascades for two of the most
The identification of a TRADD-TRAF2 complex raised the possibility that TRAFs might associate indirectly with important biological activities of TNF, NF-B activation and programmed cell death (Hsu et al., 1995) . Our finding TNFR1 and TRADD might associate indirectly with that this interaction is TNF dependent suggests that the death domains of TRADD and TNFR1 do not interact with each other as monomers. Instead, the trimeric TNF is likely to induce trimeric or perhaps higher order aggregates of TNFR1 (Banner et al., 1993) that are stabilized by the self-associating death domain of TNFR1 (Song et al., 1994; Boldin et al., 1995b) . These aggregated which the two (or more) TNFR1-TRADD signal transduction pathways diverge. The TRAF2 pathway, which is shared with TNFR2, CD40, and probably other members of the TNFR superfamily, ultimately would result in NF-B activation. On the surface, the results described here would seem to contradict our earlier characterization of TRADD deletion mutants (Hsu et al., 1995) . In those experiments we showed that a TRADD mutant ) lacking amino acids 1-194 was capable of activating NF-B when overexpressed. This result implied that the N-terminal 194 amino acids of TRADD, and by inference proteins such as TRAF2 that bind to this region of TRADD, would not be required for NF-B activation. This apparent paradox can be explained by the following experimental result. We have found that the NF-B activation pathway induced by can be potently inhibited by overexpression of the TRAF2(87-501) dominant-negative mutant (data not shown) and is therefore TRAF2 dependent. To date, all TRAF2-dependent pathways for NF-B activation appear to require TRAF2 aggregation . Therefore, our current interpretation of these data is that TRADD(195-315) overexpression leads to aggregation of endogenous TRADD and its associated TRAF2. Baltimore, 1993; Beg and Baldwin, 1993) . Activation of the aggregated death domain of TNFR1 to initiate signaling cas-NF-B by the proinflammatory cytokines IL-1 and TNF cades for both apoptosis and NF-B activation. TRAF2 and FADD are TRADD-interacting proteins that define the NF-B and cell death (Osborn et al., 1989) results in rapid serine phosphorylapathways, respectively (see text).
tion and degradation of IB, releasing NF-B for translocation to the nucleus Palombella et al., 1994) . The phosphorylation of IB is thought to be the cytokine-regulated step that targets IB for degrada-TNFR2. We found that TNFR1-TRAF-TRAF complexes tion by the constitutive ubiquitin-proteasome pathway can indeed exist. Conversely, TNFR2-TRADD-TRAF (Thanos and Maniatis, 1995) . In this regard, TNF has complexes cannot form, presumably because TNFR2 been shown to activate a TNFR1-associated serine proand TRADD compete for binding to similar sites in TRAF tein kinase activity (VanArsdale and Ware, 1994) . If one domains. These findings were conceptually appealing assumes this kinase is required for NF-B activation by for two reasons. First, both TNFRs are independently TNF, then the essential role of the RING finger domain capable of NF-B activation (Wiegmann et al., 1992;  of TRAF2 in NF-B activation might be to regulate kinase L-greid et al., 1994; Rothe et al., 1994; Hsu et al., 1995) activity, recruit the kinase to the TNFR1 signaling comand association with TRAF2, a protein whose overexplex, or both. pression leads to NF-B activation . Second, of the two TNFRs, only TNFR1 interacts with the cell death-inducing protein TRADD (Hsu et al., 1995) , TRADD-FADD Interaction and Signaling and this receptor also exerts a far more dominant role of Apoptosis in the signaling of apoptosis than does TNFR2 (Tartaglia The strong interaction observed between the death doet al., 1991, 1993b) .
mains of TRADD and FADD suggested the possibility The role of TRAF2 in TNFR1 signaling was examined that TRADD might be able to recruit FADD to TNFR1. by expressing TRAF2(87-501), a truncated version of Indeed, low levels of FADD were found in the TNFR1 TRAF2 lacking its N-terminal RING finger domain. This complex when FADD, TRADD, and TNFR1 were coexdominant-negative TRAF2 mutant can inhibit NF-B acpressed, raising the question of whether FADD is intivation by TNFR2 and CD40 . When volved in TNFR1-mediated signaling. overexpressed in 293 cells, TRAF2(87-501) blocked NFTo address a possible role for FADD in signal trans-B activation by TNF, a process that is TNFR1 dependuction by TNFR1, we examined an N-terminal deletion dent. NF-B activation by the cytokine IL-1 was unafmutant of murine FADD obtained in our two-hybrid fected by TRAF2(87-501), demonstrating that TRAF2 is screen. Expression of FADD(80-205) completely blocked not involved in IL-1 signaling. TRAF2(87-501) overexcell death induced by TNF treatment, or by overexprespression also had no effect on TNF-mediated apoptosis.
sion of TNFR1 or TRADD, without affecting NF-B activation. The anti-apoptotic activity of FADD(80-205) in This result is consistent with TRAF2 defining a point at Experimental Procedures these assays was as potent as that of CrmA and much more potent than Bcl-2 (Hsu et al., 1995) . A similarly (Tartaglia et al., 1991; Wong and Goeddel, 1994; Hsu et al., 1995) Los et al., 1995) . Presumably, trol expression plasmid pRK5, the NF-B reporter plasmid pELAMblocks the cell death pathway at a receptor-proximal luc, and pCMV-␤gal were also described previously (Hsu et al., step that precedes protease activation, either by dis- Apoptosis mediated by TNFR1 and Fas are similar as described previously (Rothe et al., 1994 . TRAF2(348-501)/ GAL4ad was generated by cloning the appropriate coding sequence in that both signaling cascades are initiated by death into pPC86. TRAF2(1-358)/GAL4ad was provided by Dr. H. Y. Song. domains and end in activation of ICE-like protease(s). However, clear differences in these two cell death pathYeast Two-Hybrid Cloning ways have been observed  The plasmid GAL4bd-TRADD (Hsu et al., 1995) , which encodes the Schulze-Osthoff et al., 1994) . For example, Fas-medi-GAL4 DNA-binding domain fused to full-length TRADD, was used ated cell death occurs much more rapidly than that trigas bait in two-hybrid screens of HeLa (Clontech) and mouse fetal liver stromal cell (provided by L. Lasky) cDNA libraries. The isolation gered by TNFR1 (Clement and Stamenkovic, 1994; Abof positive clones and subsequent two-hybrid interaction analyses reu-Martin et al., 1995) . These differences might be due were carried out as described elsewhere (Hsu et al., 1995) . DNA to differential contributions from other, non-FADD comsequencing was performed on an Applied Biosystems model 373A ponents of the receptor complexes. It is also possible automated DNA sequencer.
that the greater affinity of FADD for Fas than for TNFR1-TRADD observed in our coimmunoprecipitation experi-
Transfections and Reporter Assays
The 293, NIH 3T3, and HtTA-1(HeLa) cell lines were maintained in ments might reflect affinity differences under physiologihigh glucose Dulbecco's modified Eagle's medium containing 10% cal conditions. In turn, the amount of FADD present in fetal calf serum, 100 g/ml penicillin G, and 100 g/ml streptomycin the respective receptor complexes might correlate with (GIBCO) . For reporter and apoptosis assays, ‫2ف‬ ϫ 10 5 cells per well potency of the death signal.
were seeded on 6-well (35 mm) dishes. For coimmunoprecipitations, ‫2ف‬ ϫ 10 6 cells per well were seeded on 100 mm plates. Cells were transfected the following day by the calcium phosphate precipitation method (Ausubel et al., 1994) . Luciferase reporter assays were per-
Conclusions
formed as described elsewhere (Hsu et al., 1995) .
The demonstration that TRADD interacts with TRAF2 and FADD, and can recruit both to TNFR1, suggested Coimmunoprecipitation and Western Blot Analysis that TRAF2 and FADD may be involved in TNFR1-We grew U937 cells (5 ϫ 10 7 ) in RPMI medium containing 10% fetal TRADD-mediated signaling. That these interactions decalf serum and 100 g/ml each of penicillin G and streptomycin, washed them in warm PBS, and incubated them for 15 min in the fine two distinct signaling pathways emanating from presence or absence of TNF (100 ng/ml). Cells were lysed in 1 ml TRADD (Figure 9 ) is supported by the ability of TRAF2 of lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, and FADD to activate NF-B and induce apoptosis, re-1 mM EDTA, 30 mM NaF, 2 mM sodium pyrophosphate, 10 g/ml spectively. This hypothesis is further strengthened by aprotinin, 10 g/ml leupeptin). Lysates were incubated with 25 g the effectiveness of dominant-negative mutants at seof monoclonal antibody 985 or mouse IgG for 2 hr at 4ЊC, then mixed with 25 l of a 1:1 slurry of protein GammaBind G-Sepharose, and lectively inhibiting one pathway or the other: TRAF2(87-incubated for another 2 hr. The Sepharose beads were washed 501) blocks NF-B activation by TNFR1 and FADD(80-twice with 1 ml of lysis buffer, twice with 1 ml of high salt (1 M NaCl) 205) blocks apoptosis. It will now be of great interest to lysis buffer, and twice more with lysis buffer. Transfected 293 cells identify downstream events in these signaling cascades from each 100 mm dish were lysed in 1 ml of E1A buffer (50 mM that connect TRAF2 to IB phosphorylation and FADD HEPES [pH 7.6], 250 mM NaCl, 0.1% NP-40, 5 mM EDTA). For each immunoprecipitation, 0.5 ml aliquots of lysates were incubated with to cysteine protease activation.
